We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong at PhilMedical 2023 Expo | More to Expect!

By LabMedica International staff writers
Posted on 19 Sep 2023
From 23 to 25 August 2023, the MEDICAL PHILIPPINES 2023 Expo was held at the SMX Convention Center in Manila, Philippines. More...
As the largest and most professional medical devices expo in Philippines, it attracted the participation of many famous companies in the industry. As an innovative leader in the field of molecular diagnostics in China, Tianlong Technology showcased its advanced technology, products and solutions, as well as professional services on this expo.

At the exhibition, Tianlong’s Panall 8000 All-in-one Molecular Diagnosis System, which can realize "joint detection of multiple pathogens", the compact and flexible Gentier Mini Series Portable Real Time PCR System, as well as the GeneFlex Automatic Nucleic Acid Extractor, received wide attention from the visitors.

On the first day of the expo, the head of Department of Emergency Medical and Trauma Services, Hospital Kuala Lumpur visited Tianlong’s booth and had a deep communication with Tianlong processionals. Hospital Kuala Lumpur is now the largest hospital under the Ministry of Health of Malaysia and is considered to be one of the biggest hospital in Asia.

During the expo, Tianlong's professional team had deep communication with customers, introducing and demonstrating product features, technical advantages and service system.

Tianlong not only achieved good attention on the exhibition, but also developed cooperation opportunities, opening up new channels and opportunities for the future development of the enterprise.

The successful participation in the expo is also an important step in Tianlong's globalization strategy. As an enterprise actively expanding overseas markets, Tianlong will continue to look at the global market and work with more international partners to promote the development of medical technology.

Stay tuned for Tianlong’s following two expos in Thailand this coming September!

Thailand LAB International
Booth No. 3G17
Dates: Sep 6 to 8, 2023
Venue: BITEC, Bangkok, Thailand

Medical Fair Thailand
Booth No. T05
Dates: Sep 13 to 15, 2023
Venue: BITEC, Bangkok, Thailand



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.